CAS: 2230821-27-7
Gefitinib-Based PROTAC 3
CAS:2230821-27-7
Formula:
C47H57ClFN7O8S
Purity:
99%
Color and Shape:
Solid
Molecular weight:
934.5140
Ref: IN-DA01JK78
| 1mg | 47.00 € | ||
| 5mg | 81.00 € | ||
| 10mg | 117.00 € | ||
| 25mg | 163.00 € | ||
| 50mg | 196.00 € | ||
| 100mg | 333.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 10-F986380
| 5mg | 185.00 € | ||
| 10mg | 294.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 54-BISN0057
| 25mg | 187.00 € | ||
| 50mg | 307.00 € | ||
| 100mg | 503.00 € |
Estimated delivery in United States, on Friday 13 Dec 2024
Gefitinib-based PROTAC 3
CAS:2230821-27-7
Gefitinib-PROTAC 3 degrades EGFR in cancer cells; DC50s: 11.7 nM (HCC827) and 22.3 nM (H3255).
Formula:
C47H57ClFN7O8S
Purity:
97.29% - 98.25%
Color and Shape:
Solid
Molecular weight:
934.51
Ref: TM-T5437
| 2mg | 44.00 € | ||
| 5mg | 61.00 € | ||
| 10mg | 101.00 € | ||
| 25mg | 168.00 € | ||
| 50mg | 248.00 € | ||
| 100mg | 358.00 € |
Estimated delivery in United States, on Friday 13 Dec 2024
Gefitinib-Based PROTAC 3
CAS:2230821-27-7
Please enquire for more information about Gefitinib-Based PROTAC 3 including the price, delivery time and …
Formula:
C47H57ClFN7O8S
Purity:
Min. 95%
Molecular weight:
934.51 g/mol
Ref: 3D-FPD82127
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Friday 17 Jan 2025
